Found: 29
Select item for more details and to access through your institution.
Recent studies show that women in oncology face gender harassment, wage gaps.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 13, doi. 10.1002/cncr.34051
- By:
- Publication type:
- Article
Update to new oncology medical home standards.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 12, doi. 10.1002/cncr.34050
- By:
- Publication type:
- Article
First Person Profile: Melissa M. Hudson, MD: The director of the Division of Cancer Survivorship at St. Jude Children's Research Hospital believes that education for survivors is vital: The director of the Division of Cancer Survivorship at St. Jude Children's Research Hospital believes that education for survivors is vital.
- Published in:
- 2022
- By:
- Publication type:
- Biography
Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 47, doi. 10.1002/cncr.33918
- By:
- Publication type:
- Article
A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 160, doi. 10.1002/cncr.33906
- By:
- Publication type:
- Article
Associations between neighborhood disinvestment and breast cancer outcomes within a populous state registry.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 131, doi. 10.1002/cncr.33900
- By:
- Publication type:
- Article
Adjuvant tamoxifen adherence in men with early‐stage breast cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 59, doi. 10.1002/cncr.33899
- By:
- Publication type:
- Article
Adjuvant tamoxifen adherence in male patients with breast cancer: An ongoing challenge.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 22, doi. 10.1002/cncr.33898
- Publication type:
- Article
Patient and public involvement in the design and conduct of a large, pragmatic observational trial to investigate recurrent, high‐risk non–muscle‐invasive bladder cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 103, doi. 10.1002/cncr.33897
- By:
- Publication type:
- Article
There is more to soft tissue sarcomas than just grade and size.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 28, doi. 10.1002/cncr.33896
- Publication type:
- Article
Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 85, doi. 10.1002/cncr.33895
- By:
- Publication type:
- Article
Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 122, doi. 10.1002/cncr.33894
- By:
- Publication type:
- Article
Fecal microbiota transplantation for immunotherapy‐resistant urological tumors: Is it time? An update of the recent literature.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 14, doi. 10.1002/cncr.33893
- By:
- Publication type:
- Article
Altering the microbiome for immunotherapy‐resistant urological tumors—An intriguing but still early concept.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 20, doi. 10.1002/cncr.33891
- Publication type:
- Article
More social determinants lead to more cancer death: A tragic dose response.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 39, doi. 10.1002/cncr.33890
- Publication type:
- Article
Characterizing head and neck cancer survivors' discontinuation of survivorship care.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 192, doi. 10.1002/cncr.33888
- By:
- Publication type:
- Article
JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 65, doi. 10.1002/cncr.33885
- By:
- Publication type:
- Article
Substance use and mental health burden in head and neck and other cancer survivors: A National Health Interview Survey analysis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 112, doi. 10.1002/cncr.33881
- By:
- Publication type:
- Article
Seizures' impact on cognition and quality of life in childhood cancer survivors.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 180, doi. 10.1002/cncr.33879
- By:
- Publication type:
- Article
The importance of the person/patient/survivor's lived experience across the cancer control continuum.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 34, doi. 10.1002/cncr.33878
- By:
- Publication type:
- Article
Life‐years lost due to cancer among solid organ transplant recipients in the United States, 1987 to 2014.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 150, doi. 10.1002/cncr.33877
- By:
- Publication type:
- Article
Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy‐naive men: A prospective evaluation of the PLUM cohort.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 75, doi. 10.1002/cncr.33875
- By:
- Publication type:
- Article
Frontline treatment patterns and outcomes among older adults with acute myeloid leukemia: A population‐based analysis in the modern era.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 139, doi. 10.1002/cncr.33873
- By:
- Publication type:
- Article
Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 25, doi. 10.1002/cncr.33872
- By:
- Publication type:
- Article
Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 30, doi. 10.1002/cncr.33867
- By:
- Publication type:
- Article
Increasing referral of at‐risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 94, doi. 10.1002/cncr.33866
- By:
- Publication type:
- Article
The cumulative incidence of cisplatin‐induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 169, doi. 10.1002/cncr.33848
- By:
- Publication type:
- Article
New insights into cisplatin ototoxicity.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 43, doi. 10.1002/cncr.33847
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 1, doi. 10.1002/cncr.33005
- Publication type:
- Article